The Limits of Harm Reduction? Neil McKeganey Centre for Substance Use Research West of Scotland Science Park Glasgow Scotland

Similar documents
ANTI-DEPRESSANT MEDICATIONS

What is the most important information I should know about bortezomib? What should I discuss with my healthcare provider before receiving bortezomib?

Dexamethasone is used to treat cancer. This drug can be given in the vein (IV), by mouth, or as an eye drop.

PATIENT INFORMATION LEAFLET CARZIN XL

Package leaflet: Information for the user. Cyclizine Lactate 50 mg/ml Injection

Can hydrocodone cause swelling of the feet

JUST FOR KIDS SELECTED IMPORTANT SAFETY INFORMATION

Eloxatin Oxaliplatin concentrated solution for injection

For the Patient: Fludarabine injection Other names: FLUDARA

Discussing TECENTRIQ (atezolizumab) with your healthcare team Talking to Your Doctor

Bicillin L-A Benzathine benzylpenicillin tetrahydrate

Have a healthy discussion. Use this guide to start a. conversation. with your. healthcare provider

For the Patient: USMAVFIPI

Medications for Early/Mid Stage HD

TREANA 5mg and 10mg Film-coated Tablets

For the Patient: Bendamustine Other names: TREANDA

For the Patient: Ponatinib Other names: ICLUSIG

All medicines have risks and benefits. Your doctor has weighed the risks of you being given Mabthera SC against the benefits expected for you.

Questionnaire for Lipedema Patients

Before you are given CYRAMZA. When you must not be given it

PHARMA DYNAMICS CLOPIDOGREL 75 mg PATIENT INFORMATION LEAFLET

IMPORTANT: PLEASE READ

MEDICATION GUIDE. The risk of getting a serious skin rash is higher if you:

MEDICATION GUIDE Valproic Acid (val pro ic acid) Capsules

For the Patient: Amsacrine Other names: AMSA PD

Epiramat 25mg Film-coated Tablets

PATIENT INFORMATION LEAFLET ZOXADON TABLETS RANGE

MEDICATION GUIDE. Peganone 250 mg Tablets (PEG-ah-noan) (ethotoin tablets, USP)

OLANZAPINE-SYNTHON Olanzapine benzoate

For the Patient: Eribulin Other names: HALAVEN

PART III: CONSUMER INFORMATION

FDA APPROVED MEDICATION GUIDE

For the Patient: LUAVPG (Carboplatin Option)

For the Patient: Mitoxantrone Other names:

Patient Information VERSACLOZ (VER sa kloz) (clozapine) Oral Suspension

Signs and Symptoms Of Common Health Concerns

1. Have you ever had or now have: 2. Have you ever had or now have:

For the Patient: Cobimetinib tablets Other names: COTELLIC

ILOMEDIN (I lom ED in) iloprost (as trometamol)

For the Patient: Rituximab injection Other names: RITUXAN

Patient Information IXEMPRA Kit (pronounced as ǐk-'sĕm-pră) (ixabepilone) What is the most important information I should know about IXEMPRA?

WELCOME TO THE NORTHSHORE UNIVERSITY HEALTHSYSTEM SLEEP CENTERS

Patient Information Montelukast Sodium Tablets and Montelukast Sodium Chewable Tablets

Olanzapine generichealth tablets Olanzapine benzoate

Before you take Nupentin. When you must not take it

For the Patient: Paclitaxel Other names: TAXOL

IMIPENEM+CILASTATIN RBX

PRODUCT MONOGRAPH. FLOCTAFENINE Floctafenine Tablets 200 mg and 400 mg THERAPEUTIC CLASSIFICATION. Anti-inflammatory, Analgesic

For the Patient: LUAVPEM

For the Patient: GIPAJGEM Other Names: Adjuvant chemotherapy for pancreatic cancer using Gemcitabine

(sunitinib malate) for Kidney Cancer

For the Patient: GIPGEM Other Names: Metastatic cancer of the pancreas, gallbladder or bile duct.

For the Patient: Trastuzumab emtansine Other names: KADCYLA

DBL Docetaxel, Concentrated Injection

Johanna M. Hoeller, DC PS

For the Patient: Olaparib tablets Other names: LYNPARZA

What is the most important information I should know about tenofovir? What should I discuss with my healthcare provider before taking tenofovir?

DIVALPROEX (di val pro ex) SODIUM DELAYED-RELEASE TABLETS, USP

It may be g iven to you for other reasons. Talk with the doctor. What do I need to tell my doctor BEFORE I take this drug?

I. ALL CLAIMS: HEALTH CARE PROFESSIONALS

RHEUMATOLOGY PATIENT HISTORY FORM

Docetaxel (Taxotere )

Venlafaxine hydrochloride extended-release and other antidepressant medicines may cause serious side effects, including:

(pack li TAX ell) For treating breast cancer, lung cancer, ovarian cancer, Kaposi's sarcoma or other cancers

Methotrexate. About This Drug. Possible Side Effects. Warnings and Precautions

It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist.

For the Patient: LUAVNP

It is used to treat or prevent upset stomach and throwing up. What do I need to tell my doctor BEFORE I take this drug?

Do not g ive this drug if your child has an infection or any inflammation.

+ Color Change - + Hearing Loss - + Apnea - + Enuresis (urine - + Tremors - + Rash -

Starting KAZANO gave me MORE POWER than metformin alone, with 2 medicines in 1 tablet

PRIMAXIN Imipenem/Cilastatin sodium

28-DAY CLEANSE GUT C.A.R.E. by Dr. Vincent Pedre. Pre-Program Medical Symptoms Questionnaire

Bridges Family Wellness PC. New Patient Intake. Bridges Family Wellness Intake Form SE Lake Rd, Suite 102 Milwaukie, OR

For the Patient: Cyclosporine injection Other names: SANDIMMUNE I.V.

CENTRAL CARE POLICY SYMPTOMS OF ILLNESS. Policy: Consumers will be observed for symptoms of physical problems, distress, pain, or unusual behaviors.

CONSUMER MEDICINE INFORMATION

Sunitinib. Other Names: Sutent. About This Drug. Possible Side Effects. Warnings and Precautions

Nivolumab. Other Names: Opdivo. About this Drug. Possible Side Effects (More Common) Warnings and Precautions

IMPORTANT: PLEASE READ READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PART III: PATIENT MEDICATION INFORMATION

KAMIREN PACKAGE LEAFLET: INFORMATION FOR THE USER. What is in this leaflet? 1. WHAT KAMIREN IS AND WHAT IT IS USED FOR

MEDICATION GUIDE. BENLYSTA (ben-list-ah) (belimumab) Injection for intravenous use

For the Patient: Lenvatinib Other names: LENVIMA

Patient/Caregiver Information Brochure For Bipolar I Disorder in Adolescents

Patient Intake Form. Name: Date of Birth: Social Security No.: Address: City: State: Zip:

Scottsdale Family Health

RABEPRAZOL 10mg and 20mg Gastro-resistant Tablets

For the Patient: GIAVPG Other Names: First-line palliative chemotherapy for advanced gallbladder and bile duct cancer using Gemcitabine and Cisplatin

Symptom Review (page 1) Name Date

If you have any concerns about being given this medicine, ask your doctor or pharmacist.

It may be g iven to you for other reasons. Talk with the doctor. What do I need to tell my doctor BEFORE I take this drug?

Chemmart Baclofen Tablets Contains the active ingredient baclofen

DUODOPA. What is in this CMI. \'dew-oh-'doe-pah\ Levodopa/carbidopa (\'lee-voe-'doe-pah\ \'kah-bee-'doepah\) Consumer Medicine Information

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION

PATIENT INFORMATION LEAFLET

What do I need to tell my doctor BEFORE I take this drug?

Transcription:

The Limits of Harm Reduction? Neil McKeganey Centre for Substance Use Research West of Scotland Science Park Glasgow Scotland

Principle of Harm Reduction First Do No Harm

Hippocratic Oath I will use treatment to help the sick according to my ability and judgement but never with a view to injury and wrong-doing.

All medicines have potentially harmful side effects Agitation; constipation; dizziness; drowsiness; dry mouth; enlarged pupils; jitteriness; nausea; stuffy nose. Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest or throat; swelling of the mouth, face, lips, or tongue; unusual hoarseness; wheezing); chest pain; confusion; decreased coordination; drooling; fainting; fast, slow, or irregular heartbeat; mask-like face; muscle spasms of the face, neck, or back; muscle weakness; new or worsening mental or mood problems; numbness of an arm or leg; prolonged or painful erection; restlessness; seizures; severe or persistent constipation; severe or persistent dizziness, drowsiness, or headache; shuffling walk; sleeplessness; stiff or rigid muscles; sudden shortness of breath or vomiting; swelling of the hands, ankles, or feet; symptoms of infection (eg, fever, chills, persistent sore throat); symptoms of liver problems (eg, yellowing of the skin or eyes; dark urine; pale stools; severe or persistent nausea, stomach pain, or loss of appetite); tremor; trouble urinating; twisting or twitching movements; uncontrolled muscle movements (eg, twitching of the face or tongue; loss of balance; uncontrolled movements of arms or legs; trouble speaking, breathing, or swallowing); unusual bruising or bleeding; unusual eye movements or inability to move eyes; unusual or excessive sweating; unusual tiredness or weakness; unusually pale skin; vision changes (eg, blurred vision)

Two Hard Reduction Interventions Needle and Syringe Exchange Routes out of Prostitution

The Limits of Harm Reduction 1) 2) 3) 4) 5) 6) 7) 8) Moral or Political Climate The Cost Effectiveness of Harm Reduction The Definition of Harm and Whose Harm to Reduce The Balance Between Reducing Harm and Increasing Harm The Limits of Any Agency to Intervene in Individual s Lives The Balance of Harm and Pleasure The Competence of Agency Staff Longevity in Impact

Edinburgh GP Cohort (Kimber et al BMJ) Our results confirm the beneficial effects of opiate substitution treatment delivered in routine primary care over long periods. We found a dose-response relation between exposure to such treatment and survival before long term cessation. The overall median duration of injecting, however, was longer for injecting drug users who were exposed to opiate substitution treatment. (Kimber et al 2010) (O)piate substitution treatment was inversely related to the chances of achieving long term cessation. (Kimber et al 2010)

Conclusion Harm Reduction is Not a Call To Arms It is a set of principles and interventions which no less than any other set of public policy principles or intervention requires assessment in terms of cost, effectiveness, political acceptability, impact, duration, risks, requirements, desirability, timeliness and resources.

Conclusion Harm Reduction is Not a Call To Arms It is a set of principles and interventions which no less than any other set of public policy principles or intervention requires assessment in terms of cost, effectiveness, political acceptability, impact, duration, risks, requirements, desirability, timeliness and resources.

Conclusion Harm Reduction is Not a Call To Arms It is a set of principles and interventions which no less than any other set of public policy principles or intervention requires assessment in terms of cost, effectiveness, political acceptability, impact, duration, risks, requirements, desirability, timeliness and resources.

Conclusion Harm Reduction is Not a Call To Arms It is a set of principles and interventions which no less than any other set of public policy principles or intervention requires assessment in terms of cost, effectiveness, political acceptability, impact, duration, risks, requirements, desirability, timeliness and resources.

Conclusion Harm Reduction is Not a Call To Arms It is a set of principles and interventions which no less than any other set of public policy principles or intervention requires assessment in terms of cost, effectiveness, political acceptability, impact, duration, risks, requirements, desirability, timeliness and resources.